Literature DB >> 9580789

Dermal mast cells in scleroderma: their skin density, tryptase/chymase phenotypes and degranulation.

S Akimoto1, O Ishikawa, Y Igarashi, M Kurosawa, Y Miyachi.   

Abstract

To determine the distribution, tryptase/chymase phenotypes and degranulation of mast cells (MCs) in the dermis of patients with scleroderma, we examined MC density in the skin of 22 patients with systemic sclerosis (SSc) and 11 with localized scleroderma (LSc). We used antitryptase and antichymase antibodies after Carnoy's fixation. Detailed reports of two representative patients with SSc and LSc are included. In the scleroedematous stage (grade 1) showing oedema in both papillary and reticular dermis with variable homogenization of collagen bundles in the reticular dermis, MC skin density was variable in each specimen although MC skin density, as a whole, was significantly increased as compared with normal skin (P < 0.05). In the sclerotic stage (grade 2) characterized by homogenization of collagen bundles in the entire dermis, MC skin density was significantly decreased as compared with normal skin (P < 0.005). LSc showed changes similar to those in SSc. The ratio of MCTC cells (both tryptase- and chymase-positive MC) to MCT cells (tryptase-positive but chymase-negative MC) was variable in SSc and LSc. MCT cells were exclusively dominant in three patients with SSc and two with LSc. In a patient with SSc (patient 1) showing remarkable perivascular and interstitial oedema in the upper dermis, MC skin density was increased in the oedematous portion and tryptase-positive granules were distributed in extracellular locations. In another patient with LSc (patient 2), tryptase positivity increased and chymase positivity decreased in both number and intensity as the skin sclerosis progressed. MCs must have variable interactions with the lesional skin in SSc and LSc. The present study suggests that MCs are involved in the development of interstitial oedema.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9580789     DOI: 10.1046/j.1365-2133.1998.02114.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  8 in total

Review 1.  T lymphocyte and fibroblast interactions: the case of skin involvement in systemic sclerosis and other examples.

Authors:  C Chizzolini
Journal:  Springer Semin Immunopathol       Date:  1999

Review 2.  Mast cells and immunological skin diseases.

Authors:  Daniel Navi; Jun Saegusa; Fu-Tong Liu
Journal:  Clin Rev Allergy Immunol       Date:  2007-10       Impact factor: 8.667

3.  An investigation of the distribution and location of mast cells affected by the stiffness of substrates as a mechanical niche.

Authors:  Hong-Wei Yang; Xin-Yue Liu; Zhou-Feng Shen; Wei Yao; Xiao-Bo Gong; Hua-Xiong Huang; Guang-Hong Ding
Journal:  Int J Biol Sci       Date:  2018-06-22       Impact factor: 6.580

Review 4.  A Review of the Evidence for and against a Role for Mast Cells in Cutaneous Scarring and Fibrosis.

Authors:  Traci A Wilgus; Sara Ud-Din; Ardeshir Bayat
Journal:  Int J Mol Sci       Date:  2020-12-18       Impact factor: 5.923

5.  Mast cell-derived particles deliver peripheral signals to remote lymph nodes.

Authors:  Christian A Kunder; Ashley L St John; Guojie Li; Kam W Leong; Brent Berwin; Herman F Staats; Soman N Abraham
Journal:  J Exp Med       Date:  2009-10-05       Impact factor: 14.307

6.  Mast cells and company.

Authors:  Friederike Jönsson; Marc Daëron
Journal:  Front Immunol       Date:  2012-02-20       Impact factor: 7.561

7.  Altered immunohistochemical expression of mast cell tryptase and chymase in the pathogenesis of oral submucous fibrosis and malignant transformation of the overlying epithelium.

Authors:  Archana Yadav; Rajiv S Desai; Bansari A Bhuta; Jatinder S Singh; Reema Mehta; Akash P Nehete
Journal:  PLoS One       Date:  2014-05-29       Impact factor: 3.240

8.  Mastocytosis and systemic sclerosis: a clinical association.

Authors:  Gianluca Bagnato; William Neal Roberts; Davide Sciortino; Donatella Sangari; Santa Cirmi; Roneka L Ravenell; Michele Navarra; Gianfilippo Bagnato; Sebastiano Gangemi
Journal:  Clin Mol Allergy       Date:  2016-10-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.